Forward Looking Statements

This website contains certain statements that constitute “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements relate to anticipated future events, projected clinical development activities, regulatory submissions, clinical trial initiation or progression, potential commercialization pathways, research outcomes, and other statements that are not historical facts.

 

Forward-looking statements are often identified by words such as “anticipate,” “believe,” “expect,” “intend,” “plan,” “may,” “will,” “should,” “estimate,” “project,” “potential,” “propose,” or similar expressions. These statements are not guarantees of future performance and are based on management’s current expectations, assumptions, and projections regarding future events.

 

Forward-looking statements necessarily involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, regulatory outcomes, or clinical developments to differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to:

•Clinical trial design, enrollment, and outcomes

•Regulatory review processes and approval timelines

•Manufacturing scale-up and supply considerations

•Scientific, technical, and operational risks

•Changes in applicable laws and regulations

•Market, funding, and capital availability conditions

 

Although management believes that the expectations reflected in these forward-looking statements are reasonable, there can be no assurance that they will prove to be accurate. Actual results and future events may differ materially from those anticipated.

 

The Company undertakes no obligation to update or revise forward-looking statements contained on this website to reflect new information, future events, or changes in circumstances, except as required by applicable law.